SLC2A4 and B-cell chronic lymphocytic leukemia: The human immunodeficiency virus (HIV) protease inhibitor ritonavir has an off-target inhibitory effect on GLUT4 expression in CLL and MM, resulting in the reduction of cell viability (23, 24).